Brief: AFT Pharmaceuticals Says FY Net Income NZD 15.6 Mln
22/05/2024 21:38
May 23 (Reuters) - AFT Pharmaceuticals FY EBITDA NZD 26.2 million. * FY net income NZD 15.6 million * FY EBIT NZD 24.2 million * FY net debt NZD 16.2 million * FY revenue NZD 195.4 million
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV